Perrigo: Perrigo Shares Jump on FDA's Move to Reclassify Wisconsin Infant-Formula Plant

By Sabela Ojea Shares of Perrigo on Friday jumped after the pharmaceutical company said its infant-formula facility in Wisconsin would be reclassified to "no action indicated" by the U.S. Food and Drug Administration. The stock was up 22% to $29.36 in midday trading, on pace for the largest percentage increase on record. Shares are up 14% in the year to date. The FDA inspected the facility in October and November. A "no action" indication means that no objectionable conditions or practices were found during an inspection, according to the FDA. Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix (END) Dow Jones Newswires 02-28-25 1242ET By Sabela Ojea Shares of Perrigo on Friday jumped after the pharmaceutical company said its infant-formula facility in Wisconsin would be reclassified to "no action indicated" by the U.S. Food and Drug Administration. The stock was up 22% to $29.36 in midday trading, on pace for the largest percentage increase on record. Shares are up 14% in the year to date. The FDA inspected the facility in October and November. A "no action" indication means that no objectionable conditions or practices were found during an inspection, according to the FDA. Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix (END) Dow Jones Newswires 02-28-25 1242ET